Results 1 - 10 of 2041

< 1 2 3 ... 204 205 >

• K. Ravikumar, B. Sridhar, D. G. Sathe, A. V. Naidu and K. D. Sawant. Donepezilium oxalate trihydrate, a therapeutic agent for Alzheimer's disease, Acta Cryst. (2006). C62, o681-o683    

  [PubMed: 17148911]
  [DOI: 10.1107/S0108270106041187]
  
• Rui Ferreira, Marijana Blesic, Joana Trindade, Isabel Marrucho, José N. Canongia Lopes and Luís Paulo N. Rebelo. Solubility of fluorinated compounds in a range of ionic liquids. Cloud-point temperature dependence on composition and pressure, Green Chem., 2008, 10, 918.

  [DOI: 10.1039/b805902k]
  
• Alla Oleinikova and Hermann Weingärtner. Liquid–liquid coexistence curves of re-entrant phase transitions beyond the asymptotic range: tetrahydrofuran?+?water and tetrahydrofuran?+?heavy water, Phys. Chem. Chem. Phys., 2002, 4, 955.

  [DOI: 10.1039/b109349e]
  
• Kwon YE; Park JY; No KT; Kim KH; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics., Bioorganic & medicinal chemistry

  [PubMed: 17681794]
  [DOI: 10.1016/j.bmc.2007.07.003]
  
• Guo J; Hurley MM; Wright JB; Lushington GH. A docking score function for estimating ligand-protein interactions: application to acetylcholinesterase inhibition., Journal of medicinal chemistry

  [PubMed: 15481986]
  [DOI: 10.1021/jm049695v]
  
• Samadi A; Estrada M; P?rez C; Rodr?guez-Franco MI; Iriepa I; Moraleda I; Chioua M; Marco-Contelles J. Pyridonepezils, new dual AChE inhibitors as potential drugs for the treatment of Alzheimer's disease: synthesis, biological assessment, and molecular modeling., European journal of medicinal chemistry

  [PubMed: 23078965]
  [DOI: 10.1016/j.ejmech.2012.09.030]
  
• Bautista-Aguilera OM; Esteban G; Bolea I; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Samadi A; Soriano E; Unzeta M; Marco-Contelles J. Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease., European journal of medicinal chemistry

  [PubMed: 24530494]
  [DOI: 10.1016/j.ejmech.2013.12.028]
  
• Bolea I; Ju?rez-Jim?nez J; de Los R?os C; Chioua M; Pouplana R; Luque FJ; Unzeta M; Marco-Contelles J; Samadi A. Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease., Journal of medicinal chemistry

  [PubMed: 22023459]
  [DOI: 10.1021/jm200853t]
  
• Ashraf Ali M; Ismail R; Choon TS; Kumar RS; Osman H; Arumugam N; Almansour AI; Elumalai K; Singh A. AChE inhibitor: a regio- and stereo-selective 1,3-dipolar cycloaddition for the synthesis of novel substituted 5,6-dimethoxy spiro[5.3']-oxindole-spiro-[6.3?]-2,3-dihydro-1H-inden-1?-one-7-(substituted aryl)-tetrahydro-1H-pyrrolo[1,2-c][1,3]thiazole., Bioorganic & medicinal chemistry letters

  [PubMed: 22142546]
  [DOI: 10.1016/j.bmcl.2011.10.087]
  
• Camps P; Formosa X; Galdeano C; Bartolini M; Mancini F; Andrisano V; Estelrich J; Lizondo M; Bidon-Chanal A; Luque FJ; G?mez T; Mu?oz-Torrero D; Scarpellini M; Viayna E; Badia A; Clos MV; Camins A; Pall?s M. Novel donepezil-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation., Journal of medicinal chemistry

  [PubMed: 18517184]
  [DOI: 10.1021/jm8001313]